Michael J. Reardon, MD

Allison Family Distinguished Chair of Cardiovascular Research, Department of Cardiovascular Surgery
Professor of Cardiovascular Surgery, Institute for Academic Medicine
Full Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Dr. Michael J. Reardon is a native Houstonian who attended Baylor College of Medicine where he graduated with honors and as a member of AOA. He did his general surgery residency under Dr. Michael DeBakey and cardiothoracic residency under Dr. Denton Cooley. He joined the staff of the Houston Methodist Hospital in 1985 and ran a private practice until 1993. He then joined the full time faculty of BCM rising to Professor of Surgery with tenure, Chief of Cardiothoracic Surgery and Director of the thoracic residency program. He subsequently joined the academic group at the HMH as Professor of Cardiothoracic Surgery and Chief of Cardiac Surgery.

His interests have centered on aortic surgery, cardiac valve surgery and cardiac tumors. His recent research and clinical interests have focused on minimally invasive, catheter-based approaches to these areas. He serves on the national steering committee for the CoreValve, SurTAVI and reprise III TAVR trials and as national surgical PI on the SurTAVI trial, reprise III trial and the Gore type A dissection trial. Dr. Reardon also serves as the international surgical PI for the Reprise III trial.

He holds the position of Clinical Professor of Cardiothoracic Surgery at MD Anderson Cancer Center and created the multi-institution, multidisciplinary cardiac tumor team with HMH and MDA. He has operated on more primary cardiac sarcomas than any other surgeon globally and written extensively on this topic. Dr. Reardon's group recently published the largest series of surgically treated primary cardiac sarcomas in the world. Surgical Treatment of Primary Cardiac Sarcomas: Review of a Single-Institution Experience PMID 26476808

He has served as elected president of the medical staff for the HMH and received numerous awards including the Overstreet Award and Noon Award. He currently holds the Allison Family Distinguished Chair of Cardiovascular Research and is divides his time between building innovative clinical, research and educational programs.

Description of Research

He has been the principal and co-investigator on several industry and government-sponsored clinical trials and research initiatives, and he is currently on the national steering and screening committees for the Medtronic CoreValve US Pivotal Trial and the international steering committee for the SurTAVI Trial, for which he is also a national surgical principal investigator. His research interests include cardiac tumor treatment, catheter based approaches to structural heart disease, catheter based and open aortic disease treatment Having published more than 300 articles and abstracts, Dr. Reardon conducts peer reviews for publications such as the Annals of Thoracic Surgery and Circulation and is the associate editor of surgery for the Methodist DeBakey Cardiovascular Journal.

Areas Of Expertise

Cardiac tumor treatment Catheter based approaches to structural heart disease Catheter based and open aortic disease treatments Cardiac valve disease Aortic surgery Cardiac tumor surgery Complex cardiac surgery
Education & Training

Certificate, Healthcare Management , Rice University, Jesse H. Jones School of Management
Fellow , Harvard University Alley-Sheridan School of Government
Residency , Texas Heart Institute
Residency , Baylor College of Medicine
MD , Baylor College of Medicine

Transcatheter Aortic Valve Replacement: How I Teach It
Reul, RM & Reardon, MJ 2017, Annals of Thoracic Surgery, vol 103, no. 3, pp. 695-698. DOI:

Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study
Popma, JJ, Reardon, MJ, Khabbaz, K, Harrison, JK, Hughes, GC, Kodali, S, George, I, Deeb, GM, Chetcuti, S, Kipperman, R, Brown, J, Qiao, H, Slater, J & Williams, MR 2017, JACC: Cardiovascular Interventions, vol 10, no. 3, pp. 268-275. DOI:

Balloon Post-Dilation Following Implantation of a Self-Expanding Transcatheter Aortic Valve Bioprosthesis
Harrison, JK, Hughes, GC, Reardon, MJ, Stoler, R, Grayburn, P, Hebeler, R, Liu, D, Chang, Y & Popma, JJ 2017, JACC: Cardiovascular Interventions, vol 10, no. 2, pp. 168-175. DOI:

The safety of introducing a new generation TAVR device: One departments experience from introducing a second generation repositionable TAVR
Bjursten, H, Nozohoor, S, Johansson, M, Zindovic, I, Appel, CF, Sjögren, J, Dencker, M, Olivecrona, G, Harnek, J, Koul, S, Feldman, T, Reardon, MJ & Götberg, M 2017, BMC Cardiovascular Disorders, vol 17, no. 1, 25. DOI:

Optimizing Management of Patients With Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: The Importance of Distinguishing Pre-Existing From New Onset Atrial Fibrillation
Kalra, A, Reardon, MJ & Kleiman, NS 2017, JACC: Cardiovascular Interventions, vol 10, no. 1, pp. 101-103. DOI:

Change is the only constant
Reardon, MJ 2017, Journal of Thoracic and Cardiovascular Surgery. DOI:

Who's afraid of the big bad wolf?
Mumtaz, M, Gada, H, Mack, MJ & Reardon, MJ 2017, Journal of Thoracic and Cardiovascular Surgery. DOI:

One-Year Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease
OHair, DP, Bajwa, TK, Chetcuti, SJ, Deeb, GM, Stoler, RC, Hebeler, RF, Maini, B, Mumtaz, M, Kleiman, NS, Reardon, MJ, Li, S, Adams, DH, Watson, DR, Yakubov, SJ, Popma, JJ & Petrossian, G 2017, Annals of Thoracic Surgery. DOI:

Dissecting our advances
Reardon, MJ & Lumsden, AB 2017, Journal of Thoracic and Cardiovascular Surgery. DOI:

Improved Outcomes With the Evolution of a Neoadjuvant Chemotherapy Approach to Right Heart Sarcoma
Abu Saleh, WK, Ramlawi, B, Shapira, OM, Al Jabbari, O, Ravi, V, Benjamin, R, Durand, JB, Leja, MJ, Blackmon, SH, Bruckner, BA & Reardon, MJ 2017, Annals of Thoracic Surgery. DOI:

Successful Evolut R Valve-in-Valve Transcatheter Aortic Valve Replacement
Reardon, MJ, Bapat, VN & Popma, JJ 2017, Annals of Thoracic Surgery, vol 103, no. 1, pp. 365-366. DOI:

A bridge too far?
Reul, RM & Reardon, MJ 2016, Journal of Thoracic and Cardiovascular Surgery. DOI:

Prediction of Poor Outcome After Transcatheter Aortic Valve Replacement
Arnold, SV, Afilalo, J, Spertus, JA, Tang, Y, Baron, SJ, Jones, PG, Reardon, MJ, Yakubov, SJ, Adams, DH & Cohen, DJ 2016, Journal of the American College of Cardiology, vol 68, no. 17, pp. 1868-1877. DOI:

Balloon Predilation for TAVR: Over-Inflated or Under-Rated¿
Feldman, T & Reardon, MJ 2016, Journal of Invasive Cardiology, vol 28, no. 10, pp. 427-428.

Residual aortic regurgitation after transcatheter aortic valve replacement under the echocardiographic microscope
Reardon, MJ & Popma, JJ 2016, Journal of Thoracic and Cardiovascular Surgery, vol 152, no. 3, pp. 659-660. DOI:

Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report from the CoreValve Trials
Kleiman, NS, Maini, BJ, Reardon, MJ, Conte, J, Katz, S, Rajagopal, V, Kauten, J, Hartman, A, McKay, R, Hagberg, R, Huang, J & Popma, J 2016, Circulation: Cardiovascular Interventions, vol 9, no. 9, e003551. DOI:

Use of three-dimensional models to assist in the resection of malignant cardiac tumors
Al Jabbari, O, Abu Saleh, WK, Patel, AP, Igo, SR & Reardon, MJ 2016, Journal of Cardiac Surgery, vol 31, no. 9, pp. 581-583. DOI:

Outcomes in the Randomized CoreValve US Pivotal High-risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less
Reardon, MJ , Kleiman, NS, Adams, DH, Yakubov, SJ, Coselli, JS, Deeb, GM, OHair, D, Gleason, TG, Lee, JS, Hermiller, JB, Chetcuti, S, Heiser, J, Merhi, W, Zorn, GL, Tadros, P, Robinson, N, Petrossian, G, Hughes, GC, Harrison, JK, Maini, B, Mumtaz, M, Conte, JV, Resar, JR, Aharonian, V, Pfeffer, T, Oh, JK, Huang, J & Popma, JJ 2016, JAMA Cardiology. DOI:

Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial)
Skelding, KA, Yakubov, SJ, Kleiman, NS, Reardon, MJ, Adams, DH, Huang, J, Forrest, JK & Popma, JJ 2016, American Journal of Cardiology, vol 118, no. 4, pp. 560-566. DOI:

Case Report: Cardiac Tumor Resection And Repair With Porcine Xenograft
Abu Saleh, WK, Al Jabbari, O, Ramlawi, B, Bruckner, BA, Loebe, M & Reardon, MJ 2016, Houston Methodist DeBakey Cardiovascular Journal, vol 12, no. 2, pp. 116-8. DOI: